Schachtner T, Reinke P
Department of Nephrology and Internal Intensive Care, Charité University Medicine Berlin, Campus Virchow Clinic, Berlin, Germany; Berlin-Brandenburg Center of Regenerative Therapies, Berlin, Germany; Berlin Institute of Health-Charité and Max-Delbrück Center, Berlin, Germany.
Department of Nephrology and Internal Intensive Care, Charité University Medicine Berlin, Campus Virchow Clinic, Berlin, Germany; Berlin-Brandenburg Center of Regenerative Therapies, Berlin, Germany.
Transplant Proc. 2017 Jul-Aug;49(6):1237-1243. doi: 10.1016/j.transproceed.2017.01.086.
Low birth weights have been associated with a reduction in nephron number with compensatory hypertrophy of existing glomeruli. The impact of donor birth weight as an estimate of nephron number on allograft function, however, has not been examined.
We collected donor birth weight, kidney weight, and volume from 91 living kidney donor-recipient pairs before nephrectomy and after 12, 36, and 60 months. Nephron number was calculated from donor birth weight and age.
Donor birth weight, kidney weight/body surface area (BSA), and kidney volume showed a moderate positive correlation with allograft estimated glomerular filtration rate (eGFR) at 12 months (P < .05). Donor age showed a negative moderate correlation with allograft eGFR at 12 months (P = .015). The strongest correlation with allograft eGFR was observed for calculated donor kidney nephron number at 12, 36, and 60 months (R, 0.340, 0.305, and 0.476, respectively; P < .05). No impact was observed on allograft daily proteinuria of any investigated marker (P > .05). Recipients of donors with birth weight <2.5 kg had need of a significantly greater number of antihypertensive drugs (P < .05).
Calculated nephron number from donor birth weight and age is suggested to be superior to donor kidney weight/BSA and volume regarding allograft function. Calculated nephron number could estimate expected eGFR and guide decision making in cases of impaired allograft function.
低出生体重与肾单位数量减少及现有肾小球的代偿性肥大有关。然而,作为肾单位数量估计值的供体出生体重对同种异体移植功能的影响尚未得到研究。
我们收集了91对活体肾供体-受体对在肾切除术前以及术后12、36和60个月时的供体出生体重、肾脏重量和体积。根据供体出生体重和年龄计算肾单位数量。
供体出生体重、肾脏重量/体表面积(BSA)和肾脏体积与12个月时同种异体移植估计肾小球滤过率(eGFR)呈中度正相关(P <.05)。供体年龄与12个月时同种异体移植eGFR呈中度负相关(P =.015)。在12、36和60个月时,计算得出的供体肾脏肾单位数量与同种异体移植eGFR的相关性最强(R分别为0.340、0.305和0.476;P <.05)。未观察到任何研究指标对同种异体移植每日蛋白尿有影响(P >.05)。出生体重<2.5 kg的供体的受体需要显著更多的抗高血压药物(P <.05)。
就同种异体移植功能而言,根据供体出生体重和年龄计算得出的肾单位数量优于供体肾脏重量/BSA和体积。计算得出肾单位数量可以估计预期的eGFR,并在同种异体移植功能受损的情况下指导决策。